Alibaba
BABA
Meta Platforms
META
Taiwan Semiconductor
TSM
4
Micron Technology
MU
5
Oracle
ORCL
US Stock MarketDetailed Quotes
EYPT EyePoint Pharmaceuticals
- 7.300
- +0.170+2.38%
Close May 2 16:00 ET
- 7.300
- 0.0000.00%
Post 20:01 ET
502.32MMarket Cap-3.15P/E (TTM)
7.450High7.063Low690.97KVolume7.190Open7.130Pre Close5.05MTurnover1.58%Turnover RatioLossP/E (Static)68.81MShares14.00052wk High1.49P/B318.46MFloat Cap3.91052wk Low--Dividend TTM43.63MShs Float72.200Historical High--Div YieldTTM5.43%Amplitude2.190Historical Low7.303Avg Price1Lot Size
EyePoint Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.97%43.27M | -17.39%11.59M | -30.77%10.52M | 4.09%9.48M | 52.08%11.68M | 11.14%46.02M | 33.18%14.03M | 51.84%15.2M | -21.27%9.11M | -17.33%7.68M |
| Operating revenue | -5.97%43.27M | -17.39%11.59M | -30.77%10.52M | 4.09%9.48M | 52.08%11.68M | 11.14%46.02M | 33.18%14.03M | 51.84%15.2M | -21.27%9.11M | -17.33%7.68M |
| Cost of revenue | -19.86%3.71M | -18.24%816K | -38.77%736K | -21.82%1.4M | 18.59%759K | -44.37%4.63M | -70.73%998K | -14.45%1.2M | 3.34%1.79M | -63.98%640K |
| Gross profit | -4.41%39.56M | -17.33%10.77M | -30.09%9.79M | 10.43%8.08M | 55.12%10.93M | 25.12%41.39M | 82.93%13.03M | 62.66%14M | -25.61%7.31M | -6.31%7.04M |
| Operating expense | 59.22%185.42M | 90.62%56.01M | 49.79%42.54M | 41.72%42.62M | 54.72%44.25M | 3.96%116.45M | -2.57%29.38M | 5.16%28.4M | 3.54%30.07M | 10.84%28.6M |
| Selling and administrative expenses | 1.35%52.49M | 10.55%12.64M | 17.75%12.99M | -10.76%12.8M | -5.82%14.11M | -14.15%51.79M | -20.66%11.43M | -27.53%11.04M | -7.10%14.34M | -1.72%14.98M |
| -Selling and marketing expense | -98.88%131K | -72.43%51K | -94.99%24K | -99.05%50K | -99.90%6K | -54.17%11.69M | -96.87%185K | -92.04%479K | -23.17%5.29M | -14.28%5.74M |
| -General and administrative expense | 30.56%52.36M | 11.91%12.59M | 22.87%12.97M | 40.79%12.75M | 52.58%14.1M | 15.18%40.1M | 32.39%11.25M | 14.59%10.56M | 5.83%9.06M | 8.12%9.24M |
| Research and development costs | 105.57%132.93M | 141.61%43.37M | 70.14%29.54M | 89.59%29.82M | 121.32%30.14M | 30.26%64.66M | 15.49%17.95M | 55.55%17.36M | 21.07%15.73M | 36.93%13.62M |
| Operating profit | -94.30%-145.85M | -176.62%-45.24M | -127.45%-32.75M | -51.78%-34.55M | -54.59%-33.32M | 4.90%-75.07M | 29.01%-16.35M | 21.74%-14.4M | -18.45%-22.76M | -17.88%-21.55M |
| Net non-operating interest income expense | 164.36%15.07M | 68.09%3.93M | 89.64%3.39M | 213.13%3.72M | 935.13%4.04M | 638.94%5.7M | 726.15%2.34M | 8,218.18%1.79M | 725.26%1.19M | 134.42%390K |
| Non-operating interest income | 117.12%15.09M | 68.69%3.94M | 89.64%3.39M | 129.21%3.72M | 235.86%4.04M | 226.09%6.95M | 119.74%2.34M | 179.06%1.79M | 348.34%1.62M | 1,870.49%1.2M |
| Non-operating interest expense | -98.88%14K | --14K | --0 | --0 | --0 | -60.90%1.25M | --0 | --0 | -21.20%435K | -31.99%812K |
| Other net income (expense) | 93.95%-1.35M | 0 | -1.35M | |||||||
| Special income (charges) | --0 | --0 | --0 | --0 | ---- | 93.95%-1.35M | --0 | --0 | ---1.35M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -13.60%1.35M | --0 | ---- | --1.35M | ---- |
| Income before tax | -84.95%-130.78M | -194.73%-41.31M | -132.80%-29.36M | -34.49%-30.83M | -38.37%-29.28M | 30.85%-70.71M | 67.74%-14.02M | 31.53%-12.61M | -18.11%-22.92M | -0.90%-21.16M |
| Income tax | 8.43%90K | 83K | ||||||||
| Net income | -84.86%-130.87M | -193.63%-41.4M | -132.80%-29.36M | -34.49%-30.83M | -38.37%-29.28M | 30.77%-70.8M | 67.55%-14.1M | 31.53%-12.61M | -18.11%-22.92M | -0.90%-21.16M |
| Net income continuous Operations | -84.86%-130.87M | -193.63%-41.4M | -132.80%-29.36M | -34.49%-30.83M | -38.37%-29.28M | 30.77%-70.8M | 67.55%-14.1M | 31.53%-12.61M | -18.11%-22.92M | -0.90%-21.16M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -84.86%-130.87M | -193.63%-41.4M | -132.80%-29.36M | -34.49%-30.83M | -38.37%-29.28M | 30.77%-70.8M | 67.55%-14.1M | 31.53%-12.61M | -18.11%-22.92M | -0.90%-21.16M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -84.86%-130.87M | -193.63%-41.4M | -132.80%-29.36M | -34.49%-30.83M | -38.37%-29.28M | 30.77%-70.8M | 67.55%-14.1M | 31.53%-12.61M | -18.11%-22.92M | -0.90%-21.16M |
| Basic earnings per share | -27.47%-2.32 | -100.00%-0.64 | -63.64%-0.54 | 4.92%-0.58 | 1.79%-0.55 | 33.58%-1.82 | 72.41%-0.32 | 32.65%-0.33 | -17.31%-0.61 | 0.00%-0.56 |
| Diluted earnings per share | -27.47%-2.32 | -100.00%-0.64 | -63.64%-0.54 | 4.92%-0.58 | 1.79%-0.55 | 33.58%-1.82 | 72.41%-0.32 | 32.65%-0.33 | -17.31%-0.61 | 0.00%-0.56 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025